Truist Financial’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $795K | Sell |
36,841
-2,474
| -6% | -$53.4K | ﹤0.01% | 1705 |
|
|
2025
Q1 | $653K | Sell |
39,315
-10,303
| -21% | -$171K | ﹤0.01% | 1714 |
|
|
2024
Q4 | $910K | Sell |
49,618
-4,965
| -9% | -$91.1K | ﹤0.01% | 1589 |
|
|
2024
Q3 | $839K | Buy |
54,583
+4,577
| +9% | +$70.4K | ﹤0.01% | 1609 |
|
|
2024
Q2 | $813K | Buy |
50,006
+6,887
| +16% | +$112K | ﹤0.01% | 1703 |
|
|
2024
Q1 | $797K | Sell |
43,119
-20,807
| -33% | -$385K | ﹤0.01% | 1721 |
|
|
2023
Q4 | $2M | Sell |
63,926
-32,824
| -34% | -$1.03M | ﹤0.01% | 1255 |
|
|
2023
Q3 | $2.02M | Buy |
96,750
+32,068
| +50% | +$668K | ﹤0.01% | 1235 |
|
|
2023
Q2 | $1.55M | Buy |
64,682
+20,357
| +46% | +$488K | ﹤0.01% | 1367 |
|
|
2023
Q1 | $834K | Buy |
44,325
+6,539
| +17% | +$123K | ﹤0.01% | 1657 |
|
|
2022
Q4 | $602K | Sell |
37,786
-4,082
| -10% | -$65K | ﹤0.01% | 1826 |
|
|
2022
Q3 | $685K | Sell |
41,868
-7,513
| -15% | -$123K | ﹤0.01% | 1654 |
|
|
2022
Q2 | $696K | Sell |
49,381
-12,016
| -20% | -$169K | ﹤0.01% | 1714 |
|
|
2022
Q1 | $1.49M | Sell |
61,397
-20,861
| -25% | -$505K | ﹤0.01% | 1426 |
|
|
2021
Q4 | $1.92M | Sell |
82,258
-21,742
| -21% | -$507K | ﹤0.01% | 1308 |
|
|
2021
Q3 | $1.73M | Buy |
104,000
+16,973
| +20% | +$282K | ﹤0.01% | 1338 |
|
|
2021
Q2 | $2.12M | Buy |
87,027
+11,390
| +15% | +$278K | ﹤0.01% | 1259 |
|
|
2021
Q1 | $1.95M | Buy |
75,637
+32,911
| +77% | +$849K | ﹤0.01% | 1249 |
|
|
2020
Q4 | $2.28M | Buy |
42,726
+13,358
| +45% | +$714K | ﹤0.01% | 1113 |
|
|
2020
Q3 | $1.21M | Buy |
29,368
+13,002
| +79% | +$536K | ﹤0.01% | 1287 |
|
|
2020
Q2 | $793K | Buy |
16,366
+2,054
| +14% | +$99.5K | ﹤0.01% | 1383 |
|
|
2020
Q1 | $605K | Buy |
14,312
+1,211
| +9% | +$51.2K | ﹤0.01% | 1466 |
|
|
2019
Q4 | $561K | Buy |
+13,101
| New | +$561K | ﹤0.01% | 1752 |
|
|
2017
Q4 | – | Sell |
-5,836
| Closed | -$220K | – | 791 |
|
|
2017
Q3 | $220K | Buy |
+5,836
| New | +$220K | ﹤0.01% | 738 |
|